234 related articles for article (PubMed ID: 12709461)
1. Lipid-lowering therapy and risk of coronary events.
Blakely JA
JAMA; 2003 Apr 23-30; 289(16):2070-1; author reply 2071-2. PubMed ID: 12709461
[No Abstract] [Full Text] [Related]
2. Lipid-lowering therapy and risk of coronary events.
Mascitelli L; Pezzetta F
JAMA; 2003 Apr 23-30; 289(16):2071; author reply 2071-2. PubMed ID: 12709464
[No Abstract] [Full Text] [Related]
3. Lipid-lowering therapy and risk of coronary events.
Taylor WC
JAMA; 2003 Apr 23-30; 289(16):2070; author reply 2071-2. PubMed ID: 12709462
[No Abstract] [Full Text] [Related]
4. The ALLHAT lipid lowering trial--less is less.
Pasternak RC
JAMA; 2002 Dec; 288(23):3042-4. PubMed ID: 12479771
[No Abstract] [Full Text] [Related]
5. Lipid-lowering therapy and risk of coronary events.
Lardinois CK
JAMA; 2003 Apr 23-30; 289(16):2071; author reply 2071-2. PubMed ID: 12709463
[No Abstract] [Full Text] [Related]
6. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
[No Abstract] [Full Text] [Related]
7. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
Lim PO; Yee KM
Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
[No Abstract] [Full Text] [Related]
8. Statins as cardioprotective agents.
Piskur JR; Stone NJ
Am J Manag Care; 2002 Jun; 8(9 Suppl):25-9. PubMed ID: 12099325
[No Abstract] [Full Text] [Related]
9. [Clinical study of the month. The ALLHAT-LLT trial].
Kulbertus H; Scheen AJ
Rev Med Liege; 2003 Jan; 58(1):53-8. PubMed ID: 12647600
[TBL] [Abstract][Full Text] [Related]
10. Lipid-lowering in African Americans in ALLHAT-optimism bias?
Messerli FH; Bangalore S; Agarwal V
J Clin Hypertens (Greenwich); 2013 Dec; 15(12):940. PubMed ID: 24299694
[No Abstract] [Full Text] [Related]
11. [Treatment with statins for the reduction of cardiovascular risk].
Chiariello M
Ital Heart J Suppl; 2001 Mar; 2(3):221-3. PubMed ID: 11307779
[No Abstract] [Full Text] [Related]
12. Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?
Margolis KL; Davis BR; Baimbridge C; Ciocon JO; Cuyjet AB; Dart RA; Einhorn PT; Ford CE; Gordon D; Hartney TJ; Julian Haywood L; Holtzman J; Mathis DE; Oparil S; Probstfield JL; Simpson LM; Stokes JD; Wiegmann TB; Williamson JD
J Clin Hypertens (Greenwich); 2013 Dec; 15(12):941. PubMed ID: 24299695
[No Abstract] [Full Text] [Related]
13. Pravastatin and coronary heart disease.
Meyer FP
N Engl J Med; 1999 Apr; 340(14):1115-6; author reply 1116-7. PubMed ID: 10206830
[No Abstract] [Full Text] [Related]
14. Rosuvastatin for cardiovascular prevention: too many uncertainties.
Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
[TBL] [Abstract][Full Text] [Related]
15. Summaries for patients. Benefits of lowering cholesterol levels in older patients.
Ann Intern Med; 2001 May; 134(10):S-4. PubMed ID: 11357858
[No Abstract] [Full Text] [Related]
16. Pharmacogenomic importance of pravastatin.
Peters B; Maitland-van der Zee AH
Pharmacogenomics; 2008 Sep; 9(9):1207-10. PubMed ID: 18781848
[TBL] [Abstract][Full Text] [Related]
17. Pravastatin benefits elderly patients: results of PROSPER study.
Cardiovasc J S Afr; 2003; 14(1):48. PubMed ID: 12728925
[No Abstract] [Full Text] [Related]
18. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
Hague W; Forder P; Simes J; Hunt D; Tonkin A;
Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
[TBL] [Abstract][Full Text] [Related]
19. Effect of probucol on elderly hypercholesterolemic patients in the FAST study.
Sawayama Y; Maeda S; Ohnishi H; Okada K; Hayashi J
Fukuoka Igaku Zasshi; 2006 Jan; 97(1):15-24. PubMed ID: 16613215
[TBL] [Abstract][Full Text] [Related]
20. IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?
Masana L; Pedro-Botet J; Civeira F
Atherosclerosis; 2015 May; 240(1):161-2. PubMed ID: 25795557
[No Abstract] [Full Text] [Related]
[Next] [New Search]